News

Filter

Current filters:

GemzarNorth America

Hospira gains US approval of solution version of gemcitabine injection

07-08-2011

US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved…

Eli Lillygemcitabine HclGemzarGenericsHospiraNorth AmericaOncologyRegulation

US oncologists see FOLFIRINOX as the most efficacious for advanced pancreatic cancer

07-03-2011

The majority of surveyed US oncologists (57%) identified FOLFIRINOX* as the most efficacious treatment…

Eli LillyFOLFIRINOXGemzarMarkets & MarketingNorth AmericaOncologyPharmaceutical

Sanofi-Aventis and Regeneron discontinue one Ph III study of aflibercept

14-09-2009

French drug major Sanofi-Aventis and the USA’s Regeneron Pharmaceuticals, say they have discontinued…

Aventis PharmaBiotechnologyCaracDeltasoneEfudexEuropefluorouracilgemcitabine HclGemzarLillyNorth AmericaOncologyPharmaceuticalPrednisoneSanofi-Aventis

Lilly plans to appeal over Gemzar's intellectual property

07-09-2009

US drug major Eli Lilly says that the US District Court for the Eastern District of Michigan has granted…

Amino AcidsAsia-Pacificgemcitabine HclGemzarInjectionLillyNorth AmericaPharmaceuticalPhysostigmine Salicylate

COMPANY SPOTLIGHT

Menarini

Back to top